APPILI THERAPEUTICS INC-CL A (APLI.CA) Forecast, Price Target & Analyst Ratings
TSX:APLI • CA03783R1073
0.02 CAD
0 (0%)
Last: Mar 4, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APPILI THERAPEUTICS INC-CL A (APLI.CA).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateJun 23, 2026
ChartMill Buy Consensus
42.22%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.02 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
42.22%
APLI.CA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about APLI.CA.
In the previous month the buy percentage consensus was at a similar level.
APLI.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-11-15 | Maxim Group | Downgrade | Hold |
Next Earnings Forecast Details
Next Earnings Details
Release DateJun 23, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 330K -76.26% | 827.4K 150.73% | 100.4K -87.87% | -100.00% | |
| EBITDA YoY % growth | -7.9M 67.90% | -8.037M -1.73% | -8.657M -7.72% | N/A | |
| EBIT YoY % growth | -7.91M 67.87% | -8.05M -1.77% | -8.67M -7.70% | -8.058M 7.06% | |
| Operating Margin | -2,396.97% | -972.95% | -8,635.56% | N/A | |
| EPS YoY % growth | -0.08 80.00% | N/A 49.00% | N/A | -0.04 |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
APPILI THERAPEUTICS INC-CL A / APLI.CA Forecast FAQ
When does APPILI THERAPEUTICS INC-CL A (APLI.CA) report earnings?
APPILI THERAPEUTICS INC-CL A (APLI.CA) will report earnings on 2026-06-23, after the market close.
What is the number of analysts for APLI stock?
The number of analysts covering APPILI THERAPEUTICS INC-CL A (APLI.CA) is 9.